No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Dose-Response Relationship, Drug
-
Humans
-
International Normalized Ratio
-
Intracranial Embolism / blood
-
Intracranial Embolism / diagnosis
-
Intracranial Embolism / drug therapy*
-
Ischemic Attack, Transient / blood
-
Ischemic Attack, Transient / diagnosis
-
Ischemic Attack, Transient / drug therapy*
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Practice Guidelines as Topic
-
Risk
-
Secondary Prevention
-
Vitamin K / antagonists & inhibitors*
Substances
-
Anticoagulants
-
Platelet Aggregation Inhibitors
-
Vitamin K